FDA Device Intelligence
HomeBIO-RAD LABORATORIES, INC. › Whole Blood Primer

Whole Blood Primer

BIO-RAD LABORATORIES, INC. · Model 270-0351 · UDI-DI 00847817010606

JPD
3
510(k) clearances
0
Adverse events
5
Recalls
6
Facilities

Description

Whole Blood Primer

Recalls

DateFirmReason
2014-04-08Bio-Rad Laboratories, Inc.There is an issue with the buffers which impacts the quantification of the Hemoglobin F peak. Calibration and Quality control are likely to fail if the affected lots are used.
2011-05-25Tosoh Bioscience IncThe value after reconstitution appeared to be lower than the assigned value on the label. The measured value for Lot BCAL05R was 5.3%, whereas the value on the label is 5.7%. The
2010-08-18Tosoh Bioscience IncThe Beta-thalessemia Mode of the G7 Analyzer-Beta Thalassemia Mode is an automated High Performance Liquid Chromatography (HPLC) system that separates and reports HbF and HbA2 quan
2008-03-18Bio-Rad Laboratories IncSome product ROM cards have an incorrect program loaded and are unable to be updated.
2008-03-18Bio-Rad Laboratories IncSome product ROM cards have an incorrect program loaded and are unable to be updated.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.